Drugs efficacy evaluations
and much more

LUNG DISEASES BIOMARKERS
Biomarkers have the potential to become central to the clinical evaluation and monitoring of patients with lung diseases.
DIAGNOSTIC AND PROGNOSTIC BIOMARKERS
FOR THE EVALUATION OF INTERSTITIAL LUNG DISEASES
Biomarkers
Analytical Method
MMP1, MMP7 and other MMPs
Multiplex
IGFBP-2
ELISA
VEGF
Multiplex
Periostin
ELISA, Multiplex
PAI-1
ELISA
Exosomes: characterization & sequencing
ELISA
Biomarkers
Analytical Method
KL-6
Fujirebio Lumipulse
SP-A, SP-D
Multiplex
MMPs
Multiplex
TIMP-1
Siemens Centaur
Periostin
ELISA, Multiplex
IL-4, IL-6, IL-7, IL-8, IL-12,IL-18, sIL-2R
Multiplex
CCL18, CCL2, CCL15, CCL18
ELISA, Multiplex
YKL-40
ELISA
Exosomes: characterization & sequencing
ELISA